Weeks after launching its first open call for diabetes advocates, Dexcom is spotlighting the resulting group of 16 people in ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor ...

What a brutal six months it’s been for DexCom. The stock has dropped 32.6% and now trades at $58.63, rattling many ...

An international study co-led by University of Calgary researchers has found new insulin delivery technology helps control glucose levels during pregnancy for those with Type 1 diabetes, which is ...

There can be a heck of a lot of decisions to make during a round of golf. In this correspondent’s case, the decision to actually go out for a round of golf in the first place tends to be a ...

A potential IPO would cement the Boston-based company as a leader in the wearables and wellness space, particularly in a ...

The Amazing Race’s Joseph praises Adam’s efforts and uses his social media platform to raise awareness about diabetes ...

According to Mordor Intelligence, the global biosensors market is valued at USD 28.50 billion in 2025 and is projected to surpass USD 42.20 billion by 2030 reflecting an 8.17% CAGR, supported by ...

Kytopen Corp., a leader in continuous flow cellular engineering, and Excellos, Inc., a cell therapy CDMO and member of Blood Centers of America (BCA), today announced that the two companies are ...

The S&P 1500 Health Care Index gained 1.9% in September, underperforming the S&P 500, which advanced 3.7%. Read more here.

Rocky Mountain Cancer Centers (RMCC), the largest community-based oncology practice in Colorado, and IDEOlogy Health, the leading provider of non-promotional medical education, have signed an ...